English Korean Chinese
ホーム > 市場調査レポート > 医療機器 > 創傷ケア > 世界の創傷管理(2008〜2017年):北米、欧州、日本、その他の諸国における既存製品と新興製品、技術、および市場
カテゴリ
医療機器 (4760)
CT/MRI/X線 (172)
eヘルス (329)
カテーテル (240)
ディスポーザブル (77)
画像診断 (417)
核医学 (80)
眼科機器 (102)
歯科機器 (176)
心血管装置 (339)
整形外科 (341)
生体計測 (391)
創傷ケア (163)
体外診断装置 (557)
超音波 (55)
内視鏡 (160)
分子イメージング/造影剤 (28)
市場調査レポート

世界の創傷管理(2008〜2017年):北米、欧州、日本、その他の諸国における既存製品と新興製品、技術、および市場

Worldwide Wound Management, 2009: Established and Emerging Products, Technologies and Markets in the U.S., Europe, Japan and Rest of World

発行 MedMarket Diligence
出版日 2009年09月 商品コード 98660
ページ情報 英文 266 pages, 59 Exhibits, 71 Company Profiles
価格
US$ 2,850 換算 ¥ 229,339 (税抜) Hard Copy
US$ 2,850 換算 ¥ 229,339 (税抜) PDF by E-mail (Single User License)
US$ 3,050 換算 ¥ 245,433 (税抜) PDF by E-mail (Single User License) and Hard Copy
US$ 4,350 換算 ¥ 350,044 (税抜) PDF by E-mail (Site License)
US$ 5,350 換算 ¥ 430,514 (税抜) PDF by E-mail (Global License)


原文目次

Abstract

This report details the complete range of products and technologies used in wound management and wound care, from dressings, bandages, hydrogels, tissue engineered products, physical treatments and others. The report details current clinical and technology developments in this huge worldwide market with high growth sectors, with data on products in development and on the market; market size and forecast; competitor market shares; competitor profiles; and market opportunity.

The report provides full year (actual) 2008 market size and share data, with forecast market data to 2017, for the U.S., Europe, Asia/Pacific and Rest of World.

This report details the current and projected market for wound management products, including dressings, closure devices, debridement, pharmacological products, tissue engineered products and others. Particular emphasis is placed on advanced and leading edge developments (i.e., those approaching wound management from novel perspective) such as growth factors, stem cells, gene therapy and other approaches, while baseline data (current and forecast market size and current competitor market shares) is provided for established segments -- multiple dressings types (film, foam, alginate, antibacterial, non-adherent), hydrogels, hydrocolloids, pharmaceuticals, and physical treatments. The report details the clinical and technology developments underlying the huge and evolving worldwide wound care market, with data on products in development and on the market; market size and forecast; competitor market shares; competitor profiles; and market opportunity. Separate size, growth and competitor data are presented for the U.S., leading western European countries, Japan and the Rest of World category. The report profiles leading and emerging companies, with profiles providing detailed profile information on major competitors, brief profiles of companies with less sizeable current or potential positions in the market, and additional profiles of companies with novel or advanced wound care research activities in the market.

The report establishes the current worldwide market size for major technology segments as a baseline for and projecting growth in the market over a ten-year forecast and assesses and projects the composition of the market as technologies gain or lose relative market performance over this period.

Report Statistics:

  • 266 pages
  • 59 Exhibits
  • 71 Company Profiles

Methodology

MedMarket Diligence Reports are produced through primary and secondary research. Data is gathered from published sources on products and technologies on the market and under development. Clinicians and industry representatives are interviewed for their knowledge and insights on product development, market development, clinical practice and trends associated with the evolving use of technologies. Secondary data is used to corroborate and support assessments and projections. Reports are written and researched by industry insiders, whose familiarity with the companies, industry dynamics and other marketplace specifics facilitate the research process and ensure high quality and thorough reports.

Table of Contents

EXECUTIVE SUMMARY

  • Acute Wounds
  • Burns
  • Chronic Wounds
  • Products Used in Advanced Wound Management
    • Film Dressings
    • Hydrocolloid Dressings
    • Foam Dressings
    • Alginate Dressings
    • Hydrogels
    • Non-Adherent Dressings
    • Anti-Microbial Dressings
    • Wound Cleansers and Debriding Agents
    • Skin Replacements and Substitutes
    • Pharmacological Products
    • Physical Therapies
  • The Market
  • The Industry

SECTION 1: BACKGROUND

  • 1.1 Industry Structure
  • 1.2 A Complex Industry
  • 1.3 Major Wound Management Corporations
  • 1.4 Historical Perspective and Technology Breakthroughs
  • 1.5 Worldwide Regulatory and Reimbursement Environment
    • 1.5.1 Cost Effectiveness
    • 1.5.2 Clinical
    • 1.5.3 Regulatory
    • 1.5.4 Reimbursement
      • 1.5.4.1 U.S.A
      • 1.5.4.2 European Union
      • 1.5.4.3 France
      • 1.5.4.4 Germany
      • 1.5.4.5 United Kingdom .
      • 1.5.4.6 Italy
      • 1.5.4.7 Belgium
      • 1.5.4.8 Spain
      • 1.5.4.9 Scandinavia.
  • 1.6 Geographical Differences in Treatments of Wounds
  • 1.7 Minimally Invasive Surgery: Impact on Wound Incidence and Prevalence
  • 1.8 Wound Management Trends
    • 1.8.1 Surgical Wounds
    • 1.8.2 Traumatic Wounds
    • 1.8.3 Burns
    • 1.8.4 Chronic Wounds
  • 1.9 Market Dynamics

SECTION 2: CLINICAL BACKGROUND AND CASELOAD

  • 2.1 Background
    • 2.1.1 A Few Figures
    • 2.1.2 Overview of Functions
    • 2.1.3 Skin Anatomy: A Summary
  • 2.2 Types of Wounds
    • 2.2.1 Classification By Severity
    • 2.2.2 Classification By Morphology
    • 2.2.3 Classification By Etiology
    • 2.2.4 Color Classification
  • 2.3 Surgical Wounds
  • 2.4 Traumatic Wounds
  • 2.5 Burns
    • 2.5.1 Debridement
    • 2.5.2 Grafting
  • 2.6 Pressure Ulcers
    • 2.6.1 Ulcer Classification
    • 2.6.2 Hospital-Acquired Ulcers
    • 2.6.3 Management of Pressure Ulcers
  • 2.7 Venous Ulcers
  • 2.8 Arterial Ulcers
  • 2.9 Diabetic Ulcers
    • 2.9.1 Prevalence
    • 2.9.2 Stages of Diabetic Ulcer
    • 2.9.3 Treatment
      • 2.9.3.1 Amputations
      • 2.9.3.2 Abnormal Scarring
    • 2.9.4 Acquired Immunodeficiency Syndrome
  • 2.10 Wound Healing Physiology
    • 2.10.1 Inflammatory Phase
    • 2.10.2 Proliferative Phase
      • 2.10.2.1 Angiogenesis
    • 2.10.3 Maturation Phase
  • 2.11 Factors Affecting Wound Healing
    • 2.11.1 Extrinsic Factors
    • 2.11.2 Mechanical Stress
    • 2.11.3 Debris
    • 2.11.4 Temperature
    • 2.11.5 Desiccation and Maceration
    • 2.11.6 Infection
    • 2.11.7 Chemical Stress
    • 2.11.8 Medication
    • 2.11.9 Other Extrinsic Factors
    • 2.11.10 Intrinsic Factors
    • 2.11.11 Health Status
    • 2.11.12 Age Factors
    • 2.11.13 Body Build
    • 2.11.14 Nutritional Status
  • 2.12 Major Treatment Categories and Regimes
  • 2.13 Incidence of Treatments, Growth Rates and Trends

SECTION 3: PRODUCTS, TECHNOLOGIES AND MARKETS

  • 3.1 Background
  • 3.2 Film Dressings
    • 3.2.1 Overview
    • 3.2.2 Product Examples
    • 3.2.3 Market and Competitive Activity
  • 3.3 Hydrocolloids
    • 3.3.1 Overview
    • 3.3.2 Product Examples
    • 3.3.3 Market and Competitive Activity
  • 3.4 Foam Dressings
    • 3.4.1 Overview
    • 3.4.2 Product Examples
    • 3.4.3 Market and Competitive Activity
  • 3.5 Alginate Dressings
    • 3.5.1 Overview
    • 3.5.2 Product Examples
    • 3.5.3 Market and Competitive Activity
  • 3.6 Hydrogels
    • 3.6.1 Overview
    • 3.6.2 Product Examples
    • 3.6.3 Market and Competitive Activity
  • 3.7 Non-Adherent Dressings
    • 3.7.1 Overview
    • 3.7.2 Product Examples
    • 3.7.3 Market and Competitive Activity
  • 3.8 Antimicrobial Dressings
    • 3.8.1 Overview
    • 3.8.2 Product Examples
    • 3.8.3 Market and Competitive Activity
  • 3.9 Tissue-Engineered Products
    • 3.9.1 Overview
    • 3.9.2 Traditional Skin Grafts
    • 3.9.3 Skin Replacements
    • 3.9.4 Product Examples
    • 3.9.5 Market and Competitive Analysis
  • 3.10 Pharmacological Products
    • 3.10.1 Overview
    • 3.10.2 Product Examples
      • 3.10.2.1 Growth Factors
      • 3.10.2.2 Growth Factors: Background.
      • 3.10.2.3 Classification
      • 3.10.2.4 Other Growth Factors
      • 3.10.2.5 Non-Growth Factor Modulators
    • 3.10.3 Market and Competitive Analysis
      • 3.10.3.1 Growth Factors
      • 3.10.3.2 Non-Growth Factor Stimulants
      • 3.10.3.3 Gene Therapy
  • 3.11 Physical Treatments
    • 3.11.1 Negative Pressure Devices
    • 3.11.2 Positive Pressure Devices
    • 3.11.3 Mechanically Assisted Wound Closure
    • 3.11.4 Other Physical Wound Therapies
      • 3.11.4.1 Hydrotherapy
      • 3.11.4.2 Electrical Stimulation
      • 3.11.4.3 Electromagnetic Stimulation Devices
      • 3.11.4.4 Ultraviolet Therapy
      • 3.11.4.5 Hyperbaric Oxygen Therapy
      • 3.11.4.6 Ultrasound Devices
      • 3.11.4.7 Laser Devices
      • 3.11.4.8 Wound Imaging/Documentation
    • 3.11.5 Market and Competitive Analysis..
      • 3.11.5.1 Pressure Relief Devices.
      • 3.11.5.2 Hydrotherapy
      • 3.11.5.3 Electrical Stimulation
      • 3.11.5.4 Hyperbaric Oxygen Therapy .

SECTION 4: COUNTRY MARKET ANALYSIS

  • 4.1 Global Overview
  • 4.2 Market Estimates
    • 4.2.1 Market Potential
    • 4.2.2 Leading Wound Care Companies
    • 4.2.3 Leading National Markets .
  • 4.3 United States ...
    • 4.3.1 Market Opportunity.
    • 4.3.2 Market for Advanced Wound Management Products.
  • 4.4 Japan .
    • 4.4.1 Wound Care Market
    • 4.4.2 Market Opportunity.
    • 4.4.3 Leading Companies.
  • 4.5 Germany
    • 4.5.1 Wound Care Market
    • 4.5.2 Leading Companies.
  • 4.6 France .
    • 4.6.1 Wound Care Market
    • 4.6.2 Leading Companies.
  • 4.7 Italy.
    • 4.7.1 Wound Care Market
    • 4.7.2 Leading Companies.
  • 4.8 United Kingdom
    • 4.8.1 Wound Care Market
    • 4.8.2 Leading Companies

SECTION 5: COMPANY PROFILES

  • 5.1 Major Companies
    • 5.1.1 3M Health Care.
    • 5.1.2 Coloplast Group
      • 5.1.2.1 Financials
    • 5.1.3 ConvaTec Inc.
    • 5.1.4 Covidien
      • 5.1.4.1 Kendall
    • 5.1.5 Derma Sciences, Inc.
    • 5.1.6 DeRoyal Industries Inc.
    • 5.1.7 Ethicon (Johnson & Johnson)
    • 5.1.8 Gentell Inc.
    • 5.1.9 Geritrex Corp
    • 5.1.10 Hartmann Group
    • 5.1.11 Hollister Incorporated
    • 5.1.12 Lohmann & Rauscher International GmbH and Co. KG
    • 5.1.13 Medline Industries
    • 5.1.14 Molnlycke Health Care AB
    • 5.1.15 Smith & Nephew plc
    • 5.1.16 Systagenix Wound Management (US), Inc.
    • 5.1.17 UDL Laboratories
  • 5.2 Specialist Companies
    • 5.2.1 Antimicrobial Dressings
      • 5.2.1.1 AcryMed Inc.
      • 5.2.1.2 Argentum Products LLC
      • 5.2.1.3 Microban International Ltd
    • 5.2.2 Oxygen Therapy
      • 5.2.2.1 Perry Baromedical
    • 5.2.3 Tissue Regeneration
      • 5.2.3.1 Perry Baromedical
      • 5.2.3.2 Celltran Limited
      • 5.2.3.3 Euroderm AG
      • 5.2.3.4 Fidia Advanced Biopolymers
      • 5.2.3.5 Forticell Bioscience, Inc.
      • 5.2.3.6 Genzyme Biosurgery
      • 5.2.3.7 Integra LifeSciences Inc.
      • 5.2.3.8 Organogenesis Inc.
      • 5.2.3.9 Kinetic Concepts Inc.
        • 5.2.3.9.1 LifeCell Corporation
    • 5.2.4 Growth Factors
      • 5.2.4.1 ES Cell International
    • 5.2.5 Electrical Therapies
      • 5.2.5.1 BioMedical Life Systems, Inc.
      • 5.2.5.2 Diapulse Corporation of America
      • 5.2.5.3 Electromedical Products International Inc.
      • 5.2.5.4 Koldcare
      • 5.2.5.5 Microvas Technologies
    • 5.2.6 Odor Control
      • 5.2.6.1 CliniMed
    • 5.2.7 Other Therapeutic Modalities
      • 5.2.7.1 AGT Sciences Ltd
      • 5.2.7.2 Agennix
      • 5.2.7.3 Advanced Medical Solutions Group plc
      • 5.2.7.4 Anodyne Therapy LLC
      • 5.2.7.5 Applied Tissue Technologies
      • 5.2.7.6 Regenesis Biomedical Inc.
      • 5.2.7.7 Roho Inc.
      • 5.2.7.8 Uluru, Inc.
      • 5.2.7.9 Oculus Innovative Sciences, Inc.
    • 5.2.8 Summary Profiles
      • 5.2.8.1 AciesHealth
      • 5.2.8.2 Bard Medical Division
      • 5.2.8.3 Brennen Medical Inc.
      • 5.2.8.4 BSN medical Ltd
      • 5.2.8.5 DermaRite Industries LLC
      • 5.2.8.6 Ferris Manufacturing Corp.
      • 5.2.8.7 Fibrogen
      • 5.2.8.8 Geistlich Pharma.
      • 5.2.8.9 Healthpoint
      • 5.2.8.10 HemCon Medical Technologies
      • 5.2.8.11 Human BioSciences, Inc.
      • 5.2.8.12 Hymed Group Corporation
      • 5.2.8.13 Innocol, Inc.
      • 5.2.8.14 Laboratoires Urgo
      • 5.2.8.15 LifeWave Ltd
      • 5.2.8.16 Longport Inc.
      • 5.2.8.17 Nagor Ltd
      • 5.2.8.18 Oculus Innovative Sciences, Inc.
      • 5.2.8.19 Pioneer Surgical Technology, Inc.
      • 5.2.8.20 Unomedical
      • 5.2.8.21 Swiss American Products, Inc.
        • 5.2.8.21.1 Wound Care Products
      • 5.2.8.22 Wound Care Innovations, LLC

APPENDIX: LIST OF COMPANIES

List of Exhibits

  • Exhibit ES-1: Advanced Wound Care Market, by Segment, 2008 & 2017
  • Exihbit ES-2: Advanced Wound Care Market Shares by Competitor, 2008
  • Exhibit 1-1: Worldwide Wound Prevalence by Etiology, 2008
  • Exhibit 1-2: Advanced Wound Management, Worldwide Market Forecast, 2008 - 2017
  • Exhibit 1-3: Total World Wound Management Products, Market Forecast, 2008 - 2017
  • Exhibit 2-1: Classification of Wounds by Etiology
  • Exhibit 2-2: Old and New Classification Systems for Burnss
  • Exhibit 3-1: Companies and Products in the Film Dressings Category
  • Exhibit 3-2: Film Dressings, Worldwide Market Forecast, 2008 - 2017
  • Exhibit 3-3: Film Dressings, Worldwide Market Share by Supplier, 2007, 2008
  • Exhibit 3-4: Companies and Products in the Hydrocolloid Dressings Category
  • Exhibit 3-5: Hydrocolloid Dressings, Worldwide Market Forecast, 2008 - 2017
  • Exhibit 3-6: Hydrocolloid Dressings, Worldwide Market Share by Supplier, 2007, 2008
  • Exhibit 3-7: Leading Companies and Products in the Foam Dressings Category
  • Exhibit 3-8: Foam Dressings, Worldwide Market Forecast, 2008 - 2017
  • Exhibit 3-9: Foam Dressings, Worldwide Market Share by Supplier, 2007, 2008
  • Exhibit 3-10: Companies and Products in the Alginate Dressings Category
  • Exhibit 3-11: Alginate Dressings, Worldwide Market Forecast, 2008 - 2017
  • Exhibit 3-12: Alginate Dressings, Worldwide Market Share by Supplier, 2007, 2008
  • Exhibit 3-13: Amorphous Hydrogels - Companies and Products
  • Exhibit 3-14: Impregnated Hydrogels - Companies and Products
  • Exhibit 3-15: Sheet Hydrogels, Companies and Products
  • Exhibit 3-16: Hydrogel Dressings, Worldwide Market Forecast, 2008 - 2017
  • Exhibit 3-17: Hydrogel Dressings, Worldwide Market Share by Supplier, 2007, 2008
  • Exhibit 3-18: Companies and Products in the Non-Adherent Dressings Category
  • Exhibit 3-19: Non-Adherent Wound Contact Layer Dressings, Worldwide Market Forecast, 2008 - 2017
  • Exhibit 3-20: Non-Adherent Wound Contact Layer Dressings, Worldwide Market Share by Supplier, 2007, 2008
  • Exhibit 3-21: Companies and Products in the Antimicrobial Dressings Category
  • Exhibit 3-23: Antimicrobial Dressings, Worldwide Market Share by Supplier, 2007, 2008
  • Exhibit 3-24: Companies and Products in the Tissue Engineering Category
  • Exhibit 3-25: Skin Tissue Engineering Market, Worldwide Market Forecast, 2008 - 2017
  • Exhibit 3-26: Tissue Engineering, Worldwide Share by Supplier, 2007, 2008
  • Exhibit 3-27: Growth Factors in Wound Care, Worldwide Market Forecast, 2008 - 2017
  • Exhibit 3-28: Companies Commercializing Technologies in the Physical Active Treatments Category
  • Exhibit 3-29: Physical Wound Therapies, Worldwide Market Forecast, 2008 - 2017
  • Exhibit 4-1: Summary Market Forecasts for Major Advanced Wound Management Product Groups, 2008 - 2017
  • Exhibit 4-2: Leading Global Wound Care Companies by Market Share
  • Exhibit 4-3: Leading Global Wound Care Companies, Market Share, 2008
  • Exhibit 4-4: National Shares of the Global Advanced Wound Management Market, 2008
  • Exhibit 4-5: Forecast U.S. Sales for Advanced Wound Management Products, 2008 - 2017
  • Exhibit 4-6: Forecast U.S. Sales Growth for the Main Types of Advanced Wound Management Products, 2008 - 2017
  • Exhibit 4-7: Japanese Sales for Advanced Wound Management Products, 2008 - 2017
  • Exhibit 4-8: Japanese Sales Growth for the Main Types of Advanced Wound Management Products, 2008 - 2017
  • Exhibit 4-9: German Sales for Advanced Wound Management Products, 2008 - 2017
  • Exhibit 4-10: German Sales Growth for the Main Types of Advanced Wound Management Products, 2008 - 2017
  • Exhibit 4-11: French Sales for Advanced Wound Management Products, 2008 - 2017
  • Exhibit 4-12: French Sales Growth for the Main Types of Advanced Wound Management Products, 2008 - 2017
  • Exhibit 4-13: Italian Sales for Advanced Wound Management Products, 2008 - 2016
  • Exhibit 4-14: Italian Sales Growth for the Main Types of Advanced Wound Management Products, 2008 - 2017
  • Exhibit 4-15: UK Sales for Advanced Wound Management Products, 2008 - 2017
  • Exhibit 4-16: UK Sales Growth for the Main Types of Advanced Wound Management Products, 2008 - 2017
  • Exhibit 5-1: Coloplast Revenues by Business Area (DKK Millions)
  • Exhibit 5-2: Selected Johnson & Johnson Medical Devices and Diagnostics Companies
  • Exhibit 5-3: Leading Advanced Wound Management Products and Suppliers
  • Exhibit 5-4: Integra LifeSciences Financial Data, 2007, 2008 ($ Millions), Year Ending Dec. 31
  • Exhibit 5-5: Financial Data for Uluru, Fiscal Year 2007 and 2008
  • Exhibit 5-6: Oculus Innovative Sciences, FY Fourth Quarter 2008 vs. 2009 Data (Year-End March 31)
Back to Top